-- 
Novartis Increases Annual Cost-Savings Target From Alcon to $350 Million

-- B y   S i m e o n   B e n n e t t
-- 
2011-09-13T10:03:04Z

-- http://www.bloomberg.com/news/2011-09-13/novartis-increases-annual-cost-savings-target-from-alcon-to-350-million.html
Novartis AG (NOVN)  raised its target for
cost savings from the purchase of eye-care company Alcon to $350
million annually by 2013.  To contact the reporter on this story:
Simeon Bennett in Geneva at 
 sbennett9@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  